Ceftriaxone Sodium Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ceftriaxone Sodium Injection (injection) from Baxter Healthcare with status To Be Discontinued. The shortage was first posted on Oct 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Baxter Healthcare
- Package NDC
- 0338-5003-41
- Dosage Form
- Injection
- Presentation
- Ceftriaxone Sodium in Plastic Container, Injection, 2g/100 mL (NDC 0338-5003-41)
- Initial Posting
- Oct 30, 2026